Enrolling By Invitation OBSERVATIONAL NCT07347379
Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
Sponsor: RxSight, Inc.
Conditions
Aphakia Cataract
Updated 1 time since 2026 Last updated: Jan 8, 2026 Started: Nov 13, 2025 Primary completion: Jun 30, 2026 Completion: Sep 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Aphakia Cataract, this trial is ongoing. The trial is conducted by RxSight, Inc. and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Enrolling By Invitation
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- RxSight, Inc.
Data source: RxSight, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .